Soru

Zorluk: OrtaFormulating a Differential Diagnosis

Match each patient's unique clinical presentation and initial laboratory profile of hyperandrogenism with the most probable underlying diagnosis in order to formulate an accurate differential diagnosis.

  • A young adult female is evaluated for a multi-year history of irregular menstrual cycles, progressive facial hair growth, and difficulty losing weight. Laboratory analysis shows a mildly elevated serum free testosterone concentration and a normal dehydroepiandrosterone sulfate (DHEA-S) level.Polycystic ovary syndrome
  • A female patient in her late twenties reports a sudden, 3-month onset of a deepening voice, marked temporal balding, and clitoral enlargement. Laboratory workup reveals a serum total testosterone concentration of 220 ng/dL with a normal DHEA-S level.Sertoli-Leydig cell tumor
  • A female university student presents with persistent cystic acne and menstrual irregularity dating back to menarche. Her basal morning 17-hydroxyprogesterone is elevated, and administration of synthetic ACTH results in a pronounced further increase.Nonclassic congenital adrenal hyperplasia
  • A middle-aged female is referred due to the sudden onset of severe hirsutism, male-pattern hair loss, and central adiposity over a 4-month period. Laboratory testing demonstrates a significantly elevated DHEA-S level exceeding 800 µg/dL.Adrenocortical carcinoma

Cevap

The correct matches align gradual ovarian hyperandrogenism to Polycystic ovary syndrome; rapid, extreme ovarian virilization to Sertoli-Leydig cell tumor; ACTH-responsive hyperandrogenism to Nonclassic congenital adrenal hyperplasia; and rapid, extreme adrenal virilization to Adrenocortical carcinoma.
The differential diagnosis of female hyperandrogenism is categorized by the organ of origin (ovary vs. adrenal) and the underlying mechanism (functional vs. neoplastic). Gradual hyperandrogenism without frank virilization usually points to functional disorders. Polycystic ovary syndrome features mild testosterone elevations. Nonclassic congenital adrenal hyperplasia mimics this but is identified by elevated 17-hydroxyprogesterone. Conversely, rapid-onset virilization indicates a tumor. Ovarian tumors (Sertoli-Leydig) secrete pure testosterone, while adrenal tumors (Adrenocortical carcinoma) secrete large amounts of DHEA-S.

Adım Adım Çözüm

1
Determine the chronicity of the symptoms (gradual vs. rapid).
Gradual onset points to functional or benign etiologies (Polycystic ovary syndrome, Nonclassic congenital adrenal hyperplasia), whereas rapid onset with overt virilization indicates a neoplastic source.
Malignant and rapidly growing tumors produce profound, sudden hormonal shifts resulting in pronounced physical changes over months rather than years.
2
Evaluate the primary elevated androgen to localize the source.
Markedly elevated testosterone with normal DHEA-S isolates the source to the ovaries, while markedly elevated DHEA-S points exclusively to the adrenal glands.
DHEA-S is predominantly secreted by the adrenal cortex, making it a reliable marker for differentiating adrenal from ovarian hyperandrogenism.
3
Utilize dynamic functional testing for overlapping clinical presentations.
An elevated 17-hydroxyprogesterone level that surges following ACTH stimulation differentiates Nonclassic congenital adrenal hyperplasia from Polycystic ovary syndrome.
Both conditions cause gradual hirsutism and oligomenorrhea, but only Nonclassic congenital adrenal hyperplasia involves an enzymatic block (21-hydroxylase) in the steroidogenic pathway.

Anahtar Kavram

Formulating a differential diagnosis for hyperandrogenism requires distinguishing between ovarian and adrenal sources utilizing chronicity, testosterone levels, DHEA-S, and 17-hydroxyprogesterone testing.
Tahmini Süre:1m 30s
Bu soruyu puanla